Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study

BACKGROUND: Glycemic variability is associated with the development of diabetic complications and hypoglycemia. However, the effect of sodium-glucose transporter 2 (SGLT2) inhibitors on glycemic variability is controversial. We aimed to examine the effect of dapagliflozin as an add-on therapy to ins...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Metab J
Päätekijät: Lee, Seung-Hwan, Min, Kyung-Wan, Lee, Byung-Wan, Jeong, In-Kyung, Yoo, Soon-Jib, Kwon, Hyuk-Sang, Choi, Yoon-Hee, Yoon, Kun-Ho
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Diabetes Association 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164951/
https://ncbi.nlm.nih.gov/pubmed/32602273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2019.0203
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia